| John C Fox, MD | |
|
Uci Medical Center, 101 The City Drive South, Orange, CA 92868 | |
| (714) 456-2986 | |
| Not Available |
| Full Name | John C Fox |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | Uci Medical Center, Orange, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033299185 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 000000A68221 (California) | Primary |
| Entity Name | Regents Of The University Of |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154379394 PECOS PAC ID: 7517869605 Enrollment ID: O20040120001119 |
News Archive
Garnet BioTherapeutics, Inc., a regenerative medicine company focused on developing cell based therapies, today announced that the first patient has been treated in a Phase 2 multicenter, double-blind, placebo-controlled study of its lead product candidate GBT009 at Unity Hospital in Rochester, New York. GBT009 gives off a variety of pro-regenerative growth factors and cytokines which help repair damaged tissue and reduce inflammation, ultimately augmenting the body's ability to heal itself.
Scientists investigating the 2006 Northwick Park drug-trial disaster that left six healthy volunteers hospitalised say they have developed new pre-clinical tests that could have stopped the trial from ever going ahead.
How a T cell decides to make protein X, Y, or Z can have profound effects for fighting foreign invaders or staving off dire autoimmune reactions. Researchers at the University of Pennsylvania School of Medicine have identified the steps that control how different forms of an immune cell protein called CD45, which is critical for activating the immune system when faced with pathogens, are controlled in the arc of a body's immune response.
A team of researchers at Carnegie Mellon University found that age plays a critical role in the well-being of people newly diagnosed with Type 2 diabetes, with younger patients more susceptible to psychological distress resulting in worse health outcomes.
In an article published in the open-access journal Advance Engineering, a multinational team of researchers reported the selection and characterization of 3 potent SARS-CoV-2 antibodies - S-E6, S-B8, and S-D4 - from a pre-COVID-19 human combinatorial antibody library that was established 20 years ago.
› Verified 9 days ago
| Entity Name | Southern California Emergency Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639314255 PECOS PAC ID: 8628128196 Enrollment ID: O20090604000499 |
News Archive
Garnet BioTherapeutics, Inc., a regenerative medicine company focused on developing cell based therapies, today announced that the first patient has been treated in a Phase 2 multicenter, double-blind, placebo-controlled study of its lead product candidate GBT009 at Unity Hospital in Rochester, New York. GBT009 gives off a variety of pro-regenerative growth factors and cytokines which help repair damaged tissue and reduce inflammation, ultimately augmenting the body's ability to heal itself.
Scientists investigating the 2006 Northwick Park drug-trial disaster that left six healthy volunteers hospitalised say they have developed new pre-clinical tests that could have stopped the trial from ever going ahead.
How a T cell decides to make protein X, Y, or Z can have profound effects for fighting foreign invaders or staving off dire autoimmune reactions. Researchers at the University of Pennsylvania School of Medicine have identified the steps that control how different forms of an immune cell protein called CD45, which is critical for activating the immune system when faced with pathogens, are controlled in the arc of a body's immune response.
A team of researchers at Carnegie Mellon University found that age plays a critical role in the well-being of people newly diagnosed with Type 2 diabetes, with younger patients more susceptible to psychological distress resulting in worse health outcomes.
In an article published in the open-access journal Advance Engineering, a multinational team of researchers reported the selection and characterization of 3 potent SARS-CoV-2 antibodies - S-E6, S-B8, and S-D4 - from a pre-COVID-19 human combinatorial antibody library that was established 20 years ago.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John C Fox, MD Emergency Medicine Faculty Grp, Po Box 513266, Los Angeles, CA 90051-3266 Ph: (714) 456-2986 | John C Fox, MD Uci Medical Center, 101 The City Drive South, Orange, CA 92868 Ph: (714) 456-2986 |
News Archive
Garnet BioTherapeutics, Inc., a regenerative medicine company focused on developing cell based therapies, today announced that the first patient has been treated in a Phase 2 multicenter, double-blind, placebo-controlled study of its lead product candidate GBT009 at Unity Hospital in Rochester, New York. GBT009 gives off a variety of pro-regenerative growth factors and cytokines which help repair damaged tissue and reduce inflammation, ultimately augmenting the body's ability to heal itself.
Scientists investigating the 2006 Northwick Park drug-trial disaster that left six healthy volunteers hospitalised say they have developed new pre-clinical tests that could have stopped the trial from ever going ahead.
How a T cell decides to make protein X, Y, or Z can have profound effects for fighting foreign invaders or staving off dire autoimmune reactions. Researchers at the University of Pennsylvania School of Medicine have identified the steps that control how different forms of an immune cell protein called CD45, which is critical for activating the immune system when faced with pathogens, are controlled in the arc of a body's immune response.
A team of researchers at Carnegie Mellon University found that age plays a critical role in the well-being of people newly diagnosed with Type 2 diabetes, with younger patients more susceptible to psychological distress resulting in worse health outcomes.
In an article published in the open-access journal Advance Engineering, a multinational team of researchers reported the selection and characterization of 3 potent SARS-CoV-2 antibodies - S-E6, S-B8, and S-D4 - from a pre-COVID-19 human combinatorial antibody library that was established 20 years ago.
› Verified 9 days ago
Joseph Villarreal, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 The City Dr S, Building 1a, Room 1009, Orange, CA 92868 Phone: 714-456-5239 | |
Scott Rudkin, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: Uci Medical Center, 101 The City Drive South, Orange, CA 92868 Phone: 714-456-2986 | |
Joelle Reynard, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Building 1a, Room 1009, Orange, CA 92868 Phone: 714-456-5239 | |
Dr. Inna Shniter, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 W Stewart Dr, Orange, CA 92868 Phone: 714-771-8113 | |
Miss Shannon Louise Toohey, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 The City Drive South, Bldg 200 , Suite 710, Rt 128-01, Orange, CA 92868 Phone: 715-456-5239 | |
Wirachin Hoonpongsimanont, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-5705 |